These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24694726)

  • 21. Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women.
    Newcomb PA; Longnecker MP; Storer BE; Mittendorf R; Baron J; Clapp RW; Bogdan G; Willett WC
    Am J Epidemiol; 1995 Oct; 142(8):788-95. PubMed ID: 7572954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of breast cancer.
    Marchant DJ
    Clin Obstet Gynecol; 1982 Jun; 25(2):387-92. PubMed ID: 7105514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoplastic transformation of human breast epithelial cells by estrogens and chemical carcinogens.
    Russo J; Tahin Q; Lareef MH; Hu YF; Russo IH
    Environ Mol Mutagen; 2002; 39(2-3):254-63. PubMed ID: 11921196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety assessment of personal care products/cosmetics and their ingredients.
    Nohynek GJ; Antignac E; Re T; Toutain H
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):239-59. PubMed ID: 20005888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Environmental chemicals and breast cancer: An updated review of epidemiological literature informed by biological mechanisms.
    Rodgers KM; Udesky JO; Rudel RA; Brody JG
    Environ Res; 2018 Jan; 160():152-182. PubMed ID: 28987728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinogenicity of ethylene oxide: key findings and scientific issues.
    Jinot J; Fritz JM; Vulimiri SV; Keshava N
    Toxicol Mech Methods; 2018 Jun; 28(5):386-396. PubMed ID: 29210319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous estrogens as carcinogens through metabolic activation.
    Yager JD
    J Natl Cancer Inst Monogr; 2000; (27):67-73. PubMed ID: 10963620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
    Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
    Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of 60-Hz fields, estradiol and xenoestrogens on human breast cancer cells.
    Dees C; Garrett S; Henley D; Travis C
    Radiat Res; 1996 Oct; 146(4):444-52. PubMed ID: 8927716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus.
    Bernatsky S; Clarke A; Ramsey-Goldman R; Joseph L; Boivin JF; Rajan R; Moore AD; Leung MH; Allen A; Gordon C
    Rheumatology (Oxford); 2004 Sep; 43(9):1178-81. PubMed ID: 15226516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention.
    Rudel RA; Attfield KR; Schifano JN; Brody JG
    Cancer; 2007 Jun; 109(12 Suppl):2635-66. PubMed ID: 17503434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of long-term administration of estrogen on the occurrence of mammary cancer in women.
    Burch JC; Byrd BF
    Ann Surg; 1971 Sep; 174(3):414-8. PubMed ID: 5111284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions between hormones and chemicals in breast cancer.
    Safe SH
    Annu Rev Pharmacol Toxicol; 1998; 38():121-58. PubMed ID: 9597151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogens and organochlorine xenoestrogens and breast cancer risk.
    Starek A
    Int J Occup Med Environ Health; 2003; 16(2):113-24. PubMed ID: 12921380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer.
    Colditz GA
    J Natl Cancer Inst; 1998 Jun; 90(11):814-23. PubMed ID: 9625169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.